BFM
LPCN icon

Boothbay Fund Management’s Lipocine LPCN Stock Holding History

Boothbay Fund Management’s Portfolio LPCN Stock Details LPCN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.12M Buy
140,487
+85,594
+156% +$746K 0.01% 893
2025
Q4 		$441K Buy
+54,893
New +$185K 0.01% 1214

Other funds holding LPCN

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $273M AUM
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
SC
Stempoint Capital New York $522M AUM 281.95% 1-Year Est. Return
SFCM
Seven Fleet Capital Management Mountain View, California $318M AUM
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Boothbay Fund Management's LPCN Position: Q1 2026 in Review

Boothbay Fund Management increased its Lipocine (LPCN) stake by 156% in Q1 2026, buying an estimated $746K and bringing the position to 140,487 shares worth $1.12M. The position accounts for 0.01% of the portfolio, ranked #893.

Boothbay Fund Management first reported a position in LPCN in Q4 2025 and has held it in 2 quarters since. 47 funds tracked by Wall St. Rank hold LPCN as of Q1 2026.

  • Boothbay Fund Management held 140,487 shares of Lipocine worth $1.12M as of Q1 2026.
  • Boothbay Fund Management bought 85,594 Lipocine shares in Q1 2026, an estimated $746K.
  • Lipocine made up 0.01% of Boothbay Fund Management's portfolio in Q1 2026, its #893 holding.
  • Boothbay Fund Management first reported a position in Lipocine in Q4 2025 and has held it in 2 quarters since.
  • 47 funds tracked by Wall St. Rank held Lipocine as of Q1 2026.

Based on Boothbay Fund Management's 13F filing for Q1 2026, filed 15 May 2026.